Trading Day Review: Travere Therapeutics Inc (TVTX) Gains Momentum, Closing at 10.29

The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Travere Therapeutics Inc (NASDAQ: TVTX) closed at $10.29 in the last session, up 0.68% from day before closing price of $10.22. In other words, the price has increased by $0.68 from its previous closing price. On the day, 1.44 million shares were traded. TVTX stock price reached its highest trading level at $10.405 during the session, while it also had its lowest trading level at $9.97.

Ratios:

We take a closer look at TVTX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.75 and its Current Ratio is at 2.78. In the meantime, Its Debt-to-Equity ratio is 5.45 whereas as Long-Term Debt/Eq ratio is at 5.39.

On December 05, 2023, Citigroup Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $7 to $10.

On November 20, 2023, Citigroup started tracking the stock assigning a Neutral rating and target price of $7.Citigroup initiated its Neutral rating on November 20, 2023, with a $7 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 11 ’24 when Cline Christopher R. sold 54 shares for $6.74 per share. The transaction valued at 364 led to the insider holds 70,849 shares of the business.

Dube Eric M sold 19,122 shares of TVTX for $166,435 on Feb 01 ’24. The CHIEF EXECUTIVE OFFICER now owns 350,600 shares after completing the transaction at $8.70 per share. On Feb 01 ’24, another insider, REED ELIZABETH E, who serves as the SVP, GC & CORPORATE SECRETARY of the company, sold 4,764 shares for $8.71 each. As a result, the insider received 41,495 and left with 76,270 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TVTX now has a Market Capitalization of 783367424 and an Enterprise Value of 746339584. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.28 while its Price-to-Book (P/B) ratio in mrq is 10.57. Its current Enterprise Value per Revenue stands at 4.793 whereas that against EBITDA is -1.982.

Stock Price History:

The Beta on a monthly basis for TVTX is 0.81, which has changed by -0.34165066 over the last 52 weeks, in comparison to a change of 0.23228896 over the same period for the S&P500. Over the past 52 weeks, TVTX has reached a high of $17.57, while it has fallen to a 52-week low of $5.12. The 50-Day Moving Average of the stock is 37.50%, while the 200-Day Moving Average is calculated to be 35.83%.

Shares Statistics:

According to the various share statistics, TVTX traded on average about 1.25M shares per day over the past 3-months and 1437760 shares per day over the past 10 days. A total of 76.13M shares are outstanding, with a floating share count of 75.39M. Insiders hold about 0.98% of the company’s shares, while institutions hold 118.91% stake in the company. Shares short for TVTX as of 1719532800 were 10320666 with a Short Ratio of 8.25, compared to 1717113600 on 13466678. Therefore, it implies a Short% of Shares Outstanding of 10320666 and a Short% of Float of 15.25.

Most Popular